Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 18.05.2021

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
18.05.21Exasol - All systems go949FY20 was a year of groundwork for Exasol, with the IPO and a later fund raise injecting resources into a previously cash-strapped business. From H220, Exasol started to invest those funds into the business...
► Artikel lesen
18.05.214imprint Group - Upgrade from US reopening progress2614imprint's AGM statement indicates improving momentum in its order intake as the US economy reopens. Having lifted our forecast numbers initially in March, we are now raising our FY21 revenue projection...
► Artikel lesen
18.05.21TXT e-solutions - Strong Q1 drives upgrades313TXT e-solutions reported strong revenue and profit growth in Q121, reflecting the benefit of recent acquisitions and good cost control. Since the end of Q1, the company has signed promising contracts...
► Artikel lesen
18.05.21Murray Income Trust - Maintaining a commitment to quality and income192Murray Income Trust (MUT) invests in a diversified portfolio of mainly UK equities. It focuses on quality stocks and aims to provide a high and growing income, combined with capital growth. MUT's merger...
► Artikel lesen
18.05.21Acorn Income Fund Limited - Board proposes change of mandate and manager202The board of Acorn Income Fund (AIF) has announced the results of its strategic review ahead of the company's five-yearly discontinuation vote in August. It is proposing to change the mandate from its...
► Artikel lesen
18.05.21Newron Pharmaceuticals - Long-term generic challenge to Xadago383The FDA has notified Newron that an application for a generic safinamide (Xadago) has been filed. Xadago has new chemical entity (NCE) exclusivity until 27 March 2022. Xadago is then protected to December...
► Artikel lesen
18.05.21CASI Pharmaceuticals - Continuing to execute285CASI continues to execute on multiple fronts and demonstrates that it has become a multifaceted company. It is expanding the sales of Evomela, its proprietary formulation of melphalan for multiple myeloma...
► Artikel lesen
18.05.21Treatt - Sweet upgrades253Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management...
► Artikel lesen
18.05.21Dentsu Group - Progressive quarterly improvements313Dentsu's Q1 update shows a third successive quarter of improvement (a reducing decline in organic revenue), with Dentsu Japan down 0.9% on Q120 and Dentsu International 3.5% below prior year. Operating...
► Artikel lesen